Fundraising Fox

Aziyo Biologics

NASDAQ: ELUT

Silver Spring, US · Founded 2015 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

ML
Michelle LeRoux WilliamsExecutive
JD
Jeffrey D HametExecutive
LD
Lode DebrabandereExecutive

Board

WM
William Matthew ZugaBoard director
KR
Kevin RakinBoard director
CR
Charles Randal MillsBoard director

Investors · 1

HighCape CapitalWestport

Reported raises · per SEC filings

Form D private placements

$54.6M disclosed across 6 rounds · 2017–2023

▶$10.5MraisedOct 2023 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • W. Matthew ZugaDirector
  • C. Randal MillsExecutive Officer, Director
  • Michelle LeRoux WilliamsExecutive Officer
  • Matthew FergusonExecutive Officer
  • Jeffrey HametExecutive Officer
  • Kevin RakinDirector
  • Maybelle JordanDirector
  • David ColpmanDirector
  • Brigid A. MakesDirector
Offering amount
$10.5M
Amount sold
$10.5M
Sales commissions
$598.5K
Placement agents
Lake Street Capital Markets, LLC
First sale
Sep 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14MraisedDec 2021 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Brigid A. MakesDirector
  • Ronald LloydExecutive Officer, Director
  • Matthew FergusonExecutive Officer
  • Maybelle JordanDirector
  • Kevin RakinDirector
  • W. Matthew ZugaDirector
  • C. Randal Mills. Ph.D.Director
  • Jeffrey HametExecutive Officer
Offering amount
$14M
Amount sold
$14M
First sale
Dec 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedSep 2020 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles Randal MillsDirector
  • Jeffrey D HametExecutive Officer
  • Steven HochbergDirector
  • William Matthew ZugaDirector
  • Ronald LloydExecutive Officer, Director
  • Kevin RakinDirector
Offering amount
$5M
Amount sold
$5M
First sale
Sep 2020
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.1MraisedDec 2019 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven HotchbergDirector
  • Kevin RakinDirector
  • Charles Randal MillsDirector
  • Jeffrey D HametExecutive Officer
  • Ronald LloydExecutive Officer
  • William Matthew ZugaDirector
Offering amount
$3.5M
Amount sold
$3.1M
First sale
Dec 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedAug 2018 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William HochbergDirector
  • Michelle LeRoux WilliamsExecutive Officer
  • Kevin RakinDirector
  • Charles Randal MillsDirector
  • Ronald LloydExecutive Officer, Director
  • Jeffrey D HametExecutive Officer
  • William Matthew ZugaDirector
Offering amount
$10M
Amount sold
$10M
First sale
Jul 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12MraisedJun 2017 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles Randal MillsDirector
  • Michelle LeRoux WilliamsExecutive Officer
  • William Matthew ZugaDirector
  • Jeffrey D HametExecutive Officer
  • Lode DebrabandereExecutive Officer, Director
  • Kevin RakinDirector
Offering amount
$12M
Amount sold
$12M
First sale
May 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Aziyo Biologics's investors?
Aziyo Biologics's investors include HighCape Capital.
How much funding has Aziyo Biologics raised?
Aziyo Biologics has disclosed $54.6M raised across 6 rounds.
Where is Aziyo Biologics headquartered?
Aziyo Biologics is headquartered in Silver Spring, US.